Drug Type Fusion protein |
Synonyms Recombinant FVIII-Fc fusion protein(Kaifeng Pharmaceutical (Group) Co., Ltd.), 晟斯107, 重凝贝 + [5] |
Target |
Mechanism F8 modulators(Coagulation factor VIII modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemophilia A | NDA/BLA | CN | 23 Dec 2021 | |
Hemorrhage | Phase 3 | CN | 09 Oct 2020 | |
Von Willebrand Diseases | Phase 3 | CN | 09 Oct 2020 |
Phase 3 | 119 | ejkfjrexwt(ykogdyntpu) = winqhuwrnl ukarultaaa (gfjvgknbag ) View more | Positive | 15 Nov 2022 | |||
odxmzkuzbv(vjnbkoilhh) = mtzlyikkqz bunaxlsall (hipioeietd ) |